SEC Filing Update: #KRYS Krystal Biotech, Inc. : $329.84

Sector: Healthcare | YTD: 🔼+ 33.70% The SEC disclosed Today (30-OCT-2026) that Vanguard Portfolio Management has DECREASED #KRYS Shares by -16.67% 🔴 * Previous Holdings: 1.57M Shares * Current Holdings: 1.31M Shares * Decrease -262.47K * Decreased (%)-16.67% * Ownership: 4.43% https://www.thinksabio.com/reports/isr/KRYS The quarterly average prices of #KRYS: Q3 2025: $149.72 Q4 2025: $209.77 Q1 2026: $266.12 Q2 2026: $298.84 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2116229123341267122